Revive Therapeutics to Investigate Bucillamine’s Potential in Cancer Treatment
Go back to Revive Therapeutics to Investigate Bucillamine’s Potential in Cancer Treatment| (AMEX: RVV) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.00 | |||
| Open | $0.00 | 52 Week Low | $0.00 | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $0.00 | |||
| Volume | 0 | |||||
| (AMEX: RVVTF) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $0.55 | |||
| Open | $0.02 | 52 Week Low | $0.07 | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $0.00 | |||
| Volume | 265,946 | |||||
